| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 23.545 | 34.695 | 35.486 | 40.975 | 60.201 | 81.299 |
| Total Income - EUR | - | - | - | - | 23.884 | 36.222 | 36.565 | 40.978 | 69.347 | 81.952 |
| Total Expenses - EUR | - | - | - | - | 12.234 | 15.152 | 16.650 | 32.313 | 48.465 | 54.744 |
| Gross Profit/Loss - EUR | - | - | - | - | 11.650 | 21.070 | 19.915 | 8.666 | 20.883 | 27.208 |
| Net Profit/Loss - EUR | - | - | - | - | 11.386 | 20.743 | 19.576 | 8.380 | 20.394 | 25.118 |
| Employees | - | - | - | - | 1 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Andante Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 921 | 559 | 18.555 | 14.510 | 35.895 | 28.164 |
| Current Assets | - | - | - | - | 11.058 | 28.180 | 24.044 | 29.985 | 29.086 | 53.185 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.429 | 0 | 284 | 4.195 | 726 |
| Cash | - | - | - | - | 11.058 | 26.751 | 24.044 | 29.701 | 24.891 | 10.041 |
| Shareholders Funds | - | - | - | - | 11.428 | 26.297 | 39.731 | 41.831 | 58.472 | 79.111 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 551 | 2.442 | 2.868 | 2.664 | 6.509 | 2.238 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Andante Medical S.r.l.